Results 241 to 250 of about 3,030,865 (307)
A phosphorus‐modified single‐atom copper nanozyme delivering the IDO1 inhibitor 1‐methyl‐tryptophan enhances breast cancer radioimmunotherapy by simultaneously relieving hypoxia and inducing immunogenic cell death through dual enzyme activities while blocking tryptophan metabolism to suppress regulatory T cell function.
Wei Zhao +11 more
wiley +1 more source
Engineering high-fidelity tapasin variants to enhance MHC-I antigen presentation. [PDF]
Erdman MC +5 more
europepmc +1 more source
This study develops an MMP‐9‐responsive protein release system that transforms resident cells into drug depots through in situ genetic engineering. Anchored to the membrane, the therapeutic protein TIMP1 is selectively released upon MMP‐9 cleavage.
Yuan Zhang +11 more
wiley +1 more source
Immune evasion driven by lipid metabolic reprogramming in endocrine-resistant HR<sup>+</sup> breast cancer: antigen presentation defects and T-cell dysfunction. [PDF]
Gong L +5 more
europepmc +1 more source
Engineering Microbial Particles for Next‐Generation Biomedical Platforms
Microbe‐derived particles (MDPs), which include extracellular vesicles, outer membrane vesicles, inclusion bodies, polysaccharide particles, and virus‐like particles, represent a rapidly expanding category of bioinspired nanomaterials. With their natural origin, intrinsic biocompatibility, and highly programmable functionality, MDPs serve as a ...
Yuting Li +7 more
wiley +1 more source
Linker-directed lipid-antigen conjugates co-enhance lymph node targeting and antigen presentation for potent T cell immunity. [PDF]
Zhu J +8 more
europepmc +1 more source
In Vitro Selection of Antibodies Targeting <i>Yersinia pestis</i> Membrane Lipids Using Nanodisc-Based Antigen Presentation. [PDF]
Bolding MR +5 more
europepmc +1 more source
IFNγ regulates MR1 transcription and antigen presentation. [PDF]
Huber ME +4 more
europepmc +1 more source

